| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/21/2001 | WO2001044231A1 Improved omeprazole process and compositions thereof |
| 06/21/2001 | WO2001044229A1 Chemokine receptor binding heterocyclic compounds |
| 06/21/2001 | WO2001044227A1 Phenoxypropanolamines, preparation and therapeutic use thereof |
| 06/21/2001 | WO2001044223A1 Inhibitors of interleukin 5 gene expression |
| 06/21/2001 | WO2001044218A1 Quaternary salts of n-substituted cyclic or acyclic amines as pharmaceuticals |
| 06/21/2001 | WO2001044217A1 Aminothiazole inhibitors of cyclin dependent kinases |
| 06/21/2001 | WO2001044216A1 Trans olefinic glucokinase activators |
| 06/21/2001 | WO2001044213A1 New p2x7 receptor antagonists for use in the treatment of inflammatory, immune or cardiovascular diseases |
| 06/21/2001 | WO2001044212A1 Benzoic acid esters of oxazolidinones having a hydroxyacetylpiperazine substituent |
| 06/21/2001 | WO2001044211A1 Novel 3-oxo-2,1-benzisoxazol-1(3h)-carboxamides for treatment of cns diseases |
| 06/21/2001 | WO2001044207A2 Novel branched substituted amino derivatives of 3-amino-1-phenyl-1h[1,2,4]triazol, methods for producing them and pharmaceutical compositions containing them |
| 06/21/2001 | WO2001044206A1 Pyrazine based inhibitors of glycogen synthase kinase 3 |
| 06/21/2001 | WO2001044203A1 N-(1-phenylethyl)-5-phenyl-imidazole-2-amine compounds, their compositions and uses |
| 06/21/2001 | WO2001044201A1 Substituted imidazole neuropeptide y y5 receptor antagonists |
| 06/21/2001 | WO2001044200A2 Selective neurokinin antagonists |
| 06/21/2001 | WO2001044198A1 Amphiphilic quinolylpolyamines as transfer agents for biologically active macromolecules |
| 06/21/2001 | WO2001044197A2 2-phenyl-quinoline derivatives and their use as contracting agent for smooth muscles |
| 06/21/2001 | WO2001044195A1 Heterocycle derivatives and drugs |
| 06/21/2001 | WO2001044193A1 1,3,4-substituted piperidine analogs and uses thereof in treating addictions |
| 06/21/2001 | WO2001044192A1 Cyclic quaternary ammonium compounds |
| 06/21/2001 | WO2001044191A1 4-aminopiperidine derivatives and their use as medicine |
| 06/21/2001 | WO2001044190A1 Anthracene derivatives as anti-cancer agents |
| 06/21/2001 | WO2001044179A1 Novel succinate compounds, compositions and methods of use and preparation |
| 06/21/2001 | WO2001044178A1 Novel urea compounds, compositions and methods of use and preparation |
| 06/21/2001 | WO2001044170A1 Adamantane derivatives |
| 06/21/2001 | WO2001044167A1 Quaternary ammonium compounds and their use as anti-tussive agents |
| 06/21/2001 | WO2001044164A1 Substituted norbornylamino derivatives, method for the production thereof, use thereof as a medicament or a diagnostic reagent and medicaments containing said compounds |
| 06/21/2001 | WO2001044144A2 Process for the preparation of sodium salts of statins |
| 06/21/2001 | WO2001043775A2 Hydroxide-releasing agents as skin permeation enhancers |
| 06/21/2001 | WO2001043758A1 Nutritional composition, methods of producing said composition and methods of using said composition |
| 06/21/2001 | WO2001043753A2 Combination of ginseng and ginkgo to improve cognitive skills |
| 06/21/2001 | WO2001043751A1 Novel helicobacter pylori-binding substances and use thereof |
| 06/21/2001 | WO2001043750A1 Phospholipid compositions as anti-inflammation agents |
| 06/21/2001 | WO2001043749A2 Pharmaceutical implant containing immediate-release and sustained-release components and method of administration |
| 06/21/2001 | WO2001043748A2 Implant composition containing melengestrol acetate and trenbolone acetate |
| 06/21/2001 | WO2001043747A1 Matrix tablet for prolonged release of trimetazidine after oral administration |
| 06/21/2001 | WO2001043746A1 Medicinal composition |
| 06/21/2001 | WO2001043745A1 The use of scopolamine salts |
| 06/21/2001 | WO2001043744A1 Phenoxypropanolamines, method for producing them and pharmaceutical compositions containing them |
| 06/21/2001 | WO2001043743A1 Methods and compositions for the prevention and treatment of atherosclerosis, restenosis and related disorders |
| 06/21/2001 | WO2001043742A1 Novel processes for making- and a new crystalline form of- leflunomide |
| 06/21/2001 | WO2001043741A1 Cytotoxic n-unsubstituted indoles and cyclopent(b)indoles and method of making and using same |
| 06/21/2001 | WO2001043740A1 Antipsychotic heterocycle compounds |
| 06/21/2001 | WO2001043739A1 Inhibition of two-component signal transduction systems |
| 06/21/2001 | WO2001043738A1 Method for detecting nucleotide synthesis inhibitors having fewer side effects |
| 06/21/2001 | WO2001043737A1 Use of beta-adrenoceptor antagonists for the manufacture of a medicament for the treatment of disorders of the outer retina |
| 06/21/2001 | WO2001043736A1 Drugs for relieving hemicrania |
| 06/21/2001 | WO2001043735A1 Nitroglycerin ointment for treatment of pain associated with anal disease |
| 06/21/2001 | WO2001043734A2 Transdermal administration of phenylpropanolamine |
| 06/21/2001 | WO2001043733A2 Compositions, kits, apparatus, and methods for inhibiting cephalic inflammation |
| 06/21/2001 | WO2001043732A2 Use of retinoid receptor antagonists in the treatment of cartilage and bone pathologies |
| 06/21/2001 | WO2001043731A2 Inhibitors of adenosine kinase for the treatment of optic nerve and retinal damage |
| 06/21/2001 | WO2001043730A2 The treatment of convulsive states |
| 06/21/2001 | WO2001043728A1 Flat medicinal preparation for transmucosal administration of oxycodon or a comparable active ingredient in the oral cavity, for use in pain therapy and in addiction therapy |
| 06/21/2001 | WO2001043726A1 System and method for extended delivery of a therapeutic agent with its receptor loading dose |
| 06/21/2001 | WO2001043723A1 Novel forms of pravastatin sodium |
| 06/21/2001 | WO2001043722A2 Pharmaceutical gel and aerosol formulations and methods to administer the same to skin and mucosal surfaces |
| 06/21/2001 | WO2001043720A1 Composition in the form of a gel for receiving an active ingredient in a solution or suspension, especially for application on a mucous membrane and method of production thereof |
| 06/21/2001 | WO2001043716A1 Compositions for peeling |
| 06/21/2001 | WO2001043714A1 The use of fluorescent whitening agents |
| 06/21/2001 | WO2001043712A1 Catechol oximes and their use in cosmetic and dermatological preparations |
| 06/21/2001 | WO2001043711A1 Cosmetic skin conditioning compositions containing red yeast rice extract |
| 06/21/2001 | WO2001043704A1 A skin care composition that mediates cell to cell communication |
| 06/21/2001 | WO2001043702A1 Stabilizers for l-ascorbic acid-2-sodium phosphate |
| 06/21/2001 | WO2001043697A2 Analogs of galanthamine and lycoramine as modulators of nicotinic receptors |
| 06/21/2001 | WO2001043692A2 SALTS OF Cis-4-CYANO-4-[3-(CYCLOPENTYLOXY)-4-METHOXYPHENYL]CYCLOHEXANE-1-CARBOXYLIC ACID |
| 06/21/2001 | WO2001043570A1 Composition for improving the proliferative response during adaptation of the gastrointestinal tract and use in short bowel syndrome |
| 06/21/2001 | WO2001043558A2 Reduced calorie fat compositions |
| 06/21/2001 | WO2001043528A2 Devices and methods in intracerebrospinal delivery of morphine-6-glucuronide |
| 06/21/2001 | WO2001043525A2 Method for the preparation of citalopram |
| 06/21/2001 | WO2001035957A8 Stable salts of novel derivatives of 3,3-diphenylpropylamines |
| 06/21/2001 | WO2001026623A3 Treatment of fatigue, head injury and stroke |
| 06/21/2001 | WO2001017955A3 Hydroxyacetamidobenzenesulphonamide derivatives |
| 06/21/2001 | WO2001017527A9 Preventive and therapeutic agents for eye diseases |
| 06/21/2001 | WO2001016136A3 Tricyclic inhibitors of poly(adp-ribose) polymerases |
| 06/21/2001 | WO2001014535A3 UDP-N-ACETYLGLUCOSAMINE: GALACTOSE-β1,3-N-ACETYLGALACTOSAMINE-α-R/(GlcNAc to GalNAc) β1,6-N-ACETYLGLUCOSAMINYLTRANSFERASE, C2GnT3 |
| 06/21/2001 | WO2001014393A3 Spherical telithromycin clusters, method for the production and use thereof in the preparation of pharmaceutical forms |
| 06/21/2001 | WO2001013892A3 Large porous particles by spray-drying |
| 06/21/2001 | WO2001012787A3 Chimeric dna/rna ribozymes containing propanediol |
| 06/21/2001 | WO2001010411A3 Implantable active ingredient depot |
| 06/21/2001 | WO2001008505A9 Methods for suppressing appetite and enhancing exercise and recovery |
| 06/21/2001 | WO2000078972A8 Regulation with binding cassette transporter protein abc1 |
| 06/21/2001 | WO2000074689A8 Unfermented gel fraction from psyllium seed husks |
| 06/21/2001 | WO2000071103A3 Use of 15-deoxyspergualin for the treatment of hyperreactive inflammatory diseases and autoimmune diseases |
| 06/21/2001 | WO2000061568A8 1,4-benzothiazepine-1,1-dioxide derivatives substituted by sugar radicals, methods for the production thereof, medicaments containing these compounds and the use thereof |
| 06/21/2001 | WO2000061191A9 Heat stable coated colloidal iron oxides |
| 06/21/2001 | WO2000056315A8 Treatment of pain |
| 06/21/2001 | WO2000039095B1 Phenethyl-5-bromopyridylthiourea (pbt) and dihydroalkoxybenzyloxopyrimidine (dabo) derivatives exhibiting spermicidal activity |
| 06/21/2001 | WO2000027374B1 The use of excitatory amino acid transporter inhibitors to reduce cns white matter injury |
| 06/21/2001 | WO2000009101A3 Use of estrogenic compounds as anti-fungal agents |
| 06/21/2001 | WO1999056697A3 Pharmaceutical composition |
| 06/21/2001 | WO1998010795A9 Tumor homing molecules, conjugates derived therefrom, and methods of using same |
| 06/21/2001 | WO1997043901A9 IceA GENE AND RELATED METHODS |
| 06/21/2001 | WO1997042975A9 Chitosan related compositions for delivery of nucleic acids into a cell |
| 06/21/2001 | US20010004644 Compositions, kits, apparatus, and methods for inhibiting cephalic inflammation |
| 06/21/2001 | US20010004643 Pharmaceutical composition with sotalol combination and their use in treatment of cardiac ailments |
| 06/21/2001 | US20010004642 Amino fruit acid composition and method for the treatment of skin |
| 06/21/2001 | US20010004640 Compound such as 1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)-1H-benzimidazole-7 -carboxylate, with a compound having diuretic activity or a compound having calcium antagonistic activity |
| 06/21/2001 | US20010004639 Process for preparing arylacetylaminothiazoles |
| 06/21/2001 | US20010004637 Includes at least one of a water soluble antioxidant, a fat soluble antioxidant, a synergist, a sugar and a surfactant |